These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16567760)

  • 1. Colon cancer screening.
    Kiberd B
    CMAJ; 2006 Mar; 174(7):975; author reply 975-6. PubMed ID: 16567760
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
    Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
    CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon cancer screening.
    Peltekian KM
    CMAJ; 2006 Mar; 174(7):975; author reply 975-6. PubMed ID: 16567759
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for colorectal cancer.
    Budenholzer B; Welch HG
    Ann Intern Med; 2001 Aug; 135(3):219. PubMed ID: 11487493
    [No Abstract]   [Full Text] [Related]  

  • 7. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Colorectal carcinoma].
    Rambow A
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1278. PubMed ID: 12053293
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is population screening for colorectal cancer cost-effective?
    Pignone M
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):288-9. PubMed ID: 16265263
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening colonoscopy among persons 40 to 49 years of age.
    Romagnuolo J
    N Engl J Med; 2002 Oct; 347(15):1205-6; author reply 1205-6. PubMed ID: 12374885
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence based medicine (EBM) in practice: applying results of cost-effectiveness analyses.
    Rubenstein JH; Inadomi JM
    Am J Gastroenterol; 2006 Jun; 101(6):1169-71. PubMed ID: 16771930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness evaluation of predictive molecular diagnostics using the example of hereditary non-polyposis colorectal cancer (HNPCC)].
    Hagen A; Hessabi HK; Gorenoi V; Schönermark MP
    Gesundheitswesen; 2008 Jan; 70(1):18-27. PubMed ID: 18273760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.